Glycerophosphodiesterase 3 (GDE3) is a lysophosphatidylinositol-specific ectophospholipase C acting as an endocannabinoid signaling switch.


Journal

The Journal of biological chemistry
ISSN: 1083-351X
Titre abrégé: J Biol Chem
Pays: United States
ID NLM: 2985121R

Informations de publication

Date de publication:
13 11 2020
Historique:
received: 17 07 2020
revised: 03 09 2020
pubmed: 13 9 2020
medline: 10 3 2021
entrez: 12 9 2020
Statut: ppublish

Résumé

Endocannabinoid signaling plays a regulatory role in various (neuro)biological functions. 2-arachidonoylglycerol (2-AG) is the most abundant endocannabinoid, and although its canonical biosynthetic pathway involving phosphoinositide-specific phospholipase C and diacylglycerol lipase α is known, alternative pathways remain unsettled. Here, we characterize a noncanonical pathway implicating glycerophosphodiesterase 3 (GDE3, from

Identifiants

pubmed: 32917725
pii: S0021-9258(17)50403-2
doi: 10.1074/jbc.RA120.015278
pmc: PMC7667972
pii:
doi:

Substances chimiques

Arachidonic Acids 0
CNR2 protein, human 0
Endocannabinoids 0
GPR55 protein, human 0
Glycerides 0
Inositol Phosphates 0
Lysophospholipids 0
Monoglycerides 0
Receptor, Cannabinoid, CB2 0
Receptors, Cannabinoid 0
lysophosphatidylinositol 0
inositol 1-phosphate 15421-51-9
glyceryl 2-arachidonate 8D239QDW64
Phosphoric Diester Hydrolases EC 3.1.4.-
glycerophosphodiester phosphodiesterase EC 3.1.4.46

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

15767-15781

Informations de copyright

© 2020 Briand-Mésange et al.

Déclaration de conflit d'intérêts

Conflict of interest—The authors declare that they have no conflicts of interest with the contents of this article.

Références

Development. 2020 Jan 23;147(2):
pubmed: 31932351
Science. 2005 Sep 30;309(5744):2212-5
pubmed: 16195461
Handb Exp Pharmacol. 2015;231:185-211
pubmed: 26408161
Biochim Biophys Acta. 1984 Jan 17;792(1):72-8
pubmed: 6692000
FEBS J. 2014 Feb;281(4):998-1016
pubmed: 24373430
J Biol Chem. 2009 Sep 11;284(37):24848-56
pubmed: 19596859
Arch Biochem Biophys. 2002 Jun 1;402(1):51-8
pubmed: 12051682
Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):11026-31
pubmed: 18667693
Proc Natl Acad Sci U S A. 2016 Jan 5;113(1):26-33
pubmed: 26668358
Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Jun;1864(6):766-771
pubmed: 30905345
J Neurochem. 1993 Feb;60(2):620-5
pubmed: 8380438
J Neurochem. 1993 Nov;61(5):1874-81
pubmed: 8229000
Can J Biochem Physiol. 1959 Aug;37(8):911-7
pubmed: 13671378
Lipids. 2016 Apr;51(4):487-95
pubmed: 27021494
Neuropharmacology. 2014 Jan;76 Pt B:228-34
pubmed: 23954677
J Biol Chem. 2008 Apr 4;283(14):9341-9
pubmed: 18227059
J Neurosci. 2014 Sep 3;34(36):11929-47
pubmed: 25186741
Biochemistry. 1974 Mar 26;13(7):1455-60
pubmed: 4819758
Pflugers Arch. 2011 Aug;462(2):245-55
pubmed: 21603896
Trends Pharmacol Sci. 2015 May;36(5):277-96
pubmed: 25796370
J Lipid Res. 2015 Nov;56(11):2048-60
pubmed: 25814022
Biochim Biophys Acta. 2010 Jul;1801(7):711-20
pubmed: 20359546
Neuron. 2010 Feb 11;65(3):320-7
pubmed: 20159446
Trends Pharmacol Sci. 2018 Nov;39(11):953-966
pubmed: 30343728
Science. 2013 Jan 18;339(6117):324-8
pubmed: 23329048
Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Sep;1865(9):158761
pubmed: 32629025
Trends Pharmacol Sci. 2018 Jun;39(6):586-604
pubmed: 29588059
Anal Biochem. 1976 May 7;72:248-54
pubmed: 942051
Kidney Int. 1997 Apr;51(4):1022-7
pubmed: 9083266
J Neurosci. 2010 Feb 10;30(6):2017-24
pubmed: 20147530
Chem Biol. 2007 Dec;14(12):1347-56
pubmed: 18096503
Nat Rev Neurol. 2020 Jan;16(1):9-29
pubmed: 31831863
Methods Mol Biol. 2004;273:201-12
pubmed: 15308803
Biochim Biophys Acta. 2015 May;1851(5):537-48
pubmed: 25596343
J Biol Chem. 2003 Oct 31;278(44):43595-602
pubmed: 12933806
Cell. 2019 Jan 24;176(3):448-458.e12
pubmed: 30639101
Prostaglandins Other Lipid Mediat. 2013 Dec;107:103-16
pubmed: 23714700
J Biochem. 2017 Dec 1;162(6):449-458
pubmed: 28992041
Elife. 2017 Aug 29;6:
pubmed: 28849762
J Biol Chem. 2012 Dec 28;287(53):44234-48
pubmed: 23161546
Inflamm Regen. 2018 Oct 1;38:28
pubmed: 30288203
Biochim Biophys Acta. 2016 Dec;1861(12 Pt A):1881-1892
pubmed: 27637550
J Cell Physiol. 1992 Jun;151(3):613-22
pubmed: 1338336
Biochem Biophys Res Commun. 2007 Nov 3;362(4):928-34
pubmed: 17765871
J Lipid Res. 2009 Apr;50 Suppl:S225-30
pubmed: 19066402
Br J Pharmacol. 2010 Jun;160(3):604-14
pubmed: 20136841
Nat Rev Neurosci. 2014 Nov;15(11):757-64
pubmed: 25315390
Cancer Cell. 2016 Oct 10;30(4):548-562
pubmed: 27693046
J Biol Chem. 2000 Jan 7;275(1):605-12
pubmed: 10617657
Biosci Biotechnol Biochem. 2007 Aug;71(8):1811-8
pubmed: 17690467
Trends Immunol. 2016 Sep;37(9):608-620
pubmed: 27443914
Mol Pharmacol. 2000 May;57(5):1045-50
pubmed: 10779390
Biochem J. 2019 Dec 19;476(24):3721-3736
pubmed: 31794025
Nat Commun. 2019 Nov 22;10(1):5291
pubmed: 31757939
Prog Lipid Res. 2006 Sep;45(5):405-46
pubmed: 16678907
Immunity. 2020 Jul 14;53(1):127-142.e7
pubmed: 32562599
J Cell Biochem. 1997 Jun 15;65(4):550-64
pubmed: 9178104
Nature. 2016 Dec 22;540(7634):602-606
pubmed: 27851727
Science. 2015 Aug 28;349(6251):974-7
pubmed: 26315437
Biochim Biophys Acta. 1958 Dec;30(3):513-21
pubmed: 13618257
J Biol Chem. 2015 Feb 13;290(7):4260-71
pubmed: 25528375
Mol Biosyst. 2010 Aug;6(8):1411-8
pubmed: 20393650
Arch Biochem Biophys. 1995 Mar 10;317(2):331-6
pubmed: 7893146
J Biol Chem. 2014 Aug 8;289(32):21960-72
pubmed: 24942731
Biochimie. 2016 Jun;125:234-49
pubmed: 27059515
FEBS Lett. 1975 May 15;53(3):302-4
pubmed: 236918
Anal Bioanal Chem. 2016 Jan;408(3):733-45
pubmed: 26563111
J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Feb 1;883-884:161-71
pubmed: 21752730
Biochem J. 1981 Apr 1;195(1):301-6
pubmed: 7306057
J Lipid Res. 1964 Jan;5:126-7
pubmed: 14173318
Oncogene. 2011 Jan 13;30(2):142-52
pubmed: 20838378
ACS Chem Neurosci. 2019 Jan 16;10(1):716-727
pubmed: 30346710
J Biochem. 2009 Jan;145(1):13-20
pubmed: 18845565
Cell Chem Biol. 2016 Sep 22;23(9):1147-1156
pubmed: 27662254
Prog Lipid Res. 2018 Jul;71:1-17
pubmed: 29751000
Front Mol Neurosci. 2019 Nov 26;12:286
pubmed: 31849602
Neurochem Res. 1994 Apr;19(4):399-406
pubmed: 8065496
Oncogene. 2011 Jan 13;30(2):245-52
pubmed: 20818416
J Basic Clin Physiol Pharmacol. 2016 May 1;27(3):297-302
pubmed: 26669245
Cell. 2009 Sep 18;138(6):1209-21
pubmed: 19766572
Curr Opin Neurobiol. 2014 Dec;29:1-8
pubmed: 24747340
Biochim Biophys Acta Mol Cell Biol Lipids. 2017 Dec;1862(12):1546-1561
pubmed: 28843504
Biochem Soc Trans. 2014 Oct;42(5):1372-7
pubmed: 25233417
Metabolites. 2016 Jan 15;6(1):
pubmed: 26784247
Biochimie. 2007 Feb;89(2):197-204
pubmed: 17101204
J Pharm Biomed Anal. 2016 Jul 15;126:132-40
pubmed: 27208623

Auteurs

Fabienne Briand-Mésange (F)

Center for Physiopathology of Toulouse Purpan, University of Toulouse, Toulouse, France; National Center for Scientific Research, Toulouse, France; National Institute of Health and Medical Research, Paul Sabatier University, Toulouse, France.

Véronique Pons (V)

Institute of Metabolic and Cardiovascular Diseases, Toulouse, France; National Institute of Health and Medical Research, Paul Sabatier University, Toulouse, France.

Sophie Allart (S)

Center for Physiopathology of Toulouse Purpan, University of Toulouse, Toulouse, France; National Center for Scientific Research, Toulouse, France; National Institute of Health and Medical Research, Paul Sabatier University, Toulouse, France.

Julien Masquelier (J)

Bioanalysis and Pharmacology of Bioactive Lipids Research Group, Louvain Drug Research Institute, Catholic University of Louvain, Brussels, Belgium.

Gaëtan Chicanne (G)

Institute of Metabolic and Cardiovascular Diseases, Toulouse, France; National Institute of Health and Medical Research, Paul Sabatier University, Toulouse, France.

Nicolas Beton (N)

Center for Physiopathology of Toulouse Purpan, University of Toulouse, Toulouse, France; National Center for Scientific Research, Toulouse, France; National Institute of Health and Medical Research, Paul Sabatier University, Toulouse, France.

Bernard Payrastre (B)

Institute of Metabolic and Cardiovascular Diseases, Toulouse, France; National Institute of Health and Medical Research, Paul Sabatier University, Toulouse, France.

Giulio G Muccioli (GG)

Bioanalysis and Pharmacology of Bioactive Lipids Research Group, Louvain Drug Research Institute, Catholic University of Louvain, Brussels, Belgium.

Jérôme Ausseil (J)

Center for Physiopathology of Toulouse Purpan, University of Toulouse, Toulouse, France; National Center for Scientific Research, Toulouse, France; National Institute of Health and Medical Research, Paul Sabatier University, Toulouse, France.

Jean-Luc Davignon (JL)

Center for Physiopathology of Toulouse Purpan, University of Toulouse, Toulouse, France; National Center for Scientific Research, Toulouse, France; National Institute of Health and Medical Research, Paul Sabatier University, Toulouse, France.

Jean-Pierre Salles (JP)

Center for Physiopathology of Toulouse Purpan, University of Toulouse, Toulouse, France; National Center for Scientific Research, Toulouse, France; National Institute of Health and Medical Research, Paul Sabatier University, Toulouse, France.

Hugues Chap (H)

Center for Physiopathology of Toulouse Purpan, University of Toulouse, Toulouse, France; National Center for Scientific Research, Toulouse, France; National Institute of Health and Medical Research, Paul Sabatier University, Toulouse, France. Electronic address: hugues.chap@inserm.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH